Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT05731011
Other study ID # KA22/363
Secondary ID
Status Not yet recruiting
Phase
First received
Last updated
Start date August 25, 2023
Est. completion date December 30, 2023

Study information

Verified date July 2023
Source Baskent University
Contact Mustafa Gulsen, assocc.prof
Phone 5300407325
Email mgulsen81@hotmail.com
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This study aimed to investigate the production of reactive oxygen derivatives (ROS) and reactive nitrogen derivatives (RNT) in female patients with knee OA, and their effects on oxidative stress by evaluating before and after physical therapy in female patients with gonarthrosis who have Kellegren-Lawrence Staging Scale Stage II and III. aimed. To this study; All female cases over the age of 40 who applied to Başkent University Ankara Hospital and were diagnosed with knee OA by a specialist doctor will be included. Method After the cases participating in the study were checked by a specialist physician, the cases that did not prevent them from being included in the study; It will be graded according to the Kellegren-Lawrence Staging Scale. Stage II and III cases will be included in the study. Sociodemographic characteristics of the patients will be recorded before the treatment. 10 sessions of physical therapy program will be applied to the patients. Treatment program 20 minutes Hot pack (HP), 60-100 Hz frequency range, 60 pulse duration and 20 minutes of conventional TENS (Enraf-NoniusBDelftechpark 39, 2600 AV, Delft, The Netherlands) with the patient comfortable feeling and 10 minutes continuous around the knee A home exercise program will be given with ultrasound (Enraf-Nonius-B Delftechpark 39; 1-MHz; 1.5 watts/cm2) to strengthen the muscles around the knees. Those with acute inflammation of the knee joint, those who underwent surgery in the knee joint for any reason or any trauma to the lower extremity, those with a history of uncontrollable high blood pressure, any neurological or vestibular problems, those who have used steroid injections in the last two months, and any For this reason, patients with systemic diseases that will affect the study will be excluded from the study. Staging criteria according to Kellegren-Lawrence Staging Scale; Stage 0: Normal Stage 1: Possible osteophyte Stage 2: Definite osteophyte, suspected narrowing of joint space Stage 3: Moderate osteophyte, definite narrowing Stage 4: Extensive osteophyte, marked narrowing, sclerosis (Kellegren and Lawrence, 1957). Biochemical analyzes: To this study; Blood samples will be taken before and after treatment from a female patient over 40 years old who was diagnosed with knee OA at Başkent University Ankara Hospital. Total antioxidant level (TAS): It will be determined by an automatic measurement method based on the fact that the characteristic color formed by the 2,2'azino-bis (3-ethylbenz-thiazoline-6-sulfonic acid) (ABTS) radical is brightened by the antioxidants in the sample added to the medium (Erel, 2004). Results will be given in mmol Trolox eqivalen/L. Total oxidant level (TOS): will be determined by automatic measurement method (Erel, 2005). The oxidants in the sample have the task of converting the ferrous ion complex to a ferric ion. Ferric ion (Fe3+) formed by oxidation of iron (Fe2+) to its more stable form (Fe2O3) creates color with xylenol orange in acidic environment. The intensity of the color measured spectrophotometrically is related to the total amount of oxidant molecules present in the sample. The measurement is calibrated with hydrogen peroxide (H2O2) and the results will be given as micromolar H2O2 equivalent per liter (µmol H2O2 equiv./L) (Sydow, 1985). Nitric oxide (NO): Serum nitric oxide concentration (Mirand et al, 2001) will be measured in a spectrophotometer according to the method (PowerWawe XS, BioTek, USA). Serum samples will be deproteinized with 10% zinc sulfate. In this method, nitrate was converted to nitrite with Vanadium (III) chloride. It is based on the measurement of the complex diazonium compound as a result of the reaction of nitrite and sulfanilamide N-(1-Naphthy) ethylene diamine dihydrochloride in an acidic medium. High-density lipoprotein (HDL): It will be run in an autoanalyzer using the Biotrol trademark kit and given in mg/dl. The results will be recorded for each individual on the information sheet.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 31
Est. completion date December 30, 2023
Est. primary completion date November 15, 2023
Accepts healthy volunteers No
Gender Female
Age group 40 Years to 90 Years
Eligibility Inclusion Criteria: - Cases with Grade II and III Study Grades according to the Kellgren-Lawrence Staging Scale - women over 40 Exclusion Criteria: - Patients with acute inflammation of the knee joint, - undergoing surgery in the knee joint for any reason or any trauma to the lower extremity, - a history of uncontrollable high blood pressure, - any neurological or vestibular problem, - use of steroid injections in the last two months, - any cases with systemic disease that may affect the study

Study Design


Related Conditions & MeSH terms


Intervention

Other:
antioxidative stress
blood interventions
Device:
electrotherapy
hotpack,Tens, ultrasound

Locations

Country Name City State
Turkey The Effects of Physical Therapy on Oxidative Stress in Female Patients With Gonarthrosis Ankara

Sponsors (1)

Lead Sponsor Collaborator
Baskent University

Country where clinical trial is conducted

Turkey, 

Outcome

Type Measure Description Time frame Safety issue
Primary antioxidant level Blood samples will be taken before and after treatment. Total antioxidant level (TAS): It will be determined by an automatic measurement method based on the fact that the characteristic color formed by the 2,2'azino-bis (3-ethylbenz-thiazoline-6-sulfonic acid) (ABTS) radical is brightened by the antioxidants in the sample added to the medium (Erel, 2004). Results will be given in mmol Trolox eqivalen/L. 2 months
See also
  Status Clinical Trial Phase
Not yet recruiting NCT05233930 - Total Knee Arthroplasty and Augmented Reality-based Navigation System N/A
Not yet recruiting NCT04460989 - Assessment of Patient Satisfaction After Arthroplasty: A Comparative Study by Implant Type
Recruiting NCT02411097 - Role of Femoral Nerve Block on Prevention of Postoperative Deep Venous Thromboembolism N/A
Not yet recruiting NCT05435690 - Evaluation of a New Navigation System in Computer-assisted Total Knee Arthroplasty N/A
Completed NCT06308887 - Comparison of Ultrasound-Guided Perimeniscal Steroid and 5% Dextrose Injections in Knee Osteoarthritis Phase 4
Recruiting NCT03951545 - Clinical and Radiological Impact of Tibial Cutting Int Total Knee Arthroplasty, Accelerated Navigation Versus Extramedullary Targeting N/A
Recruiting NCT06302075 - Functional Recovery After Medial Monocompartmental Knee Prosthesis: One Day Protocol Versus Fast Protocol N/A
Not yet recruiting NCT05877027 - Exercise vs. Topical Diclofenac vs. PRP N/A
Recruiting NCT04424628 - Radiotherapy 3 vs 6 Gy in Gonarthrosis and Coxarthrosis N/A
Completed NCT04577521 - The Safety and Efficacy of Single IA-HA Injection in Patients With Knee Osteoarthritis: A Prospective Study
Recruiting NCT05814471 - Validation orthèse Pour Gonarthrose N/A
Completed NCT01773226 - Evaluation of Intra-articular Injection of Autologous Protein Solution ("APS(TM)") for the Treatment of Osteoarthritis (OA) N/A
Completed NCT02638831 - Ketorol Gel in Gonarthrosis and Low Back Pain Phase 4
Completed NCT02977936 - Management of Joint Pain Associated With Osteoarthritis of the Knee With Association of Plant Extracts.
Recruiting NCT05062109 - Multimodal Geriatric Pre-authorization Before Scheduled Orthopedic Surgery N/A
Not yet recruiting NCT06314191 - Adipose Tissue and Symptomatic Gonarthrosis N/A
Recruiting NCT02251535 - In-vivo Comparison of Different Levels of Femoral Rollback in a Primary Total Knee Arthroplasty N/A
Active, not recruiting NCT03734315 - Routine Application of Ostenil® in Patients With Gonarthrosis
Completed NCT03389607 - The Role of SCUBE-1 in Ischemia-reperfusion Injury
Completed NCT04225182 - Evaluation of the Effectiveness of a Muscular Strengthening Protocol With an Instrumented Orthosis for Gonarthrosis Patients N/A